RLAY Annual Total Long Term Liabilities
$61.71 M
-$24.14 M-28.12%
31 December 2023
Summary:
As of January 23, 2025, RLAY annual total long term liabilities is $61.71 million, with the most recent change of -$24.14 million (-28.12%) on December 31, 2023. During the last 3 years, it has risen by +$38.80 million (+169.42%). RLAY annual total long term liabilities is now -89.01% below its all-time high of $561.52 million, reached on December 31, 2019.RLAY Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RLAY Quarterly Long Term Liabilities
$44.29 M
-$1.48 M-3.23%
01 September 2024
Summary:
As of January 23, 2025, RLAY quarterly total long term liabilities is $44.29 million, with the most recent change of -$1.48 million (-3.23%) on September 1, 2024. Over the past year, it has dropped by -$33.55 million (-43.10%). RLAY quarterly long term liabilities is now -92.11% below its all-time high of $561.52 million, reached on December 31, 2019.RLAY Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RLAY Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.1% | -43.1% |
| 3 y3 years | +169.4% | -38.5% |
| 5 y5 years | -88.4% | - |
RLAY Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.5% | at low | -54.6% | at low |
| 5 y | 5-year | -89.0% | +169.4% | -92.1% | +97.0% |
| alltime | all time | -89.0% | +169.4% | -92.1% | +97.0% |
Relay Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $44.29 M(-3.2%) |
| June 2024 | - | $45.76 M(-21.8%) |
| Mar 2024 | - | $58.53 M(-5.1%) |
| Dec 2023 | $61.71 M(-28.1%) | $61.71 M(-20.7%) |
| Sept 2023 | - | $77.84 M(-3.1%) |
| June 2023 | - | $80.32 M(-4.0%) |
| Mar 2023 | - | $83.68 M(-2.5%) |
| Dec 2022 | $85.84 M | $85.84 M(-12.0%) |
| Sept 2022 | - | $97.52 M(+48.0%) |
| June 2022 | - | $65.88 M(-0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $66.22 M(-23.3%) |
| Dec 2021 | $86.31 M(+276.9%) | $86.31 M(+19.9%) |
| Sept 2021 | - | $72.01 M(+2.2%) |
| June 2021 | - | $70.49 M(+213.6%) |
| Mar 2021 | - | $22.48 M(-1.9%) |
| Dec 2020 | $22.90 M(-95.9%) | $22.90 M(+1.8%) |
| Sept 2020 | - | $22.49 M(-96.0%) |
| June 2020 | - | $560.66 M(+2306.3%) |
| Mar 2020 | - | $23.30 M(-95.9%) |
| Dec 2019 | $561.52 M(+5.4%) | $561.52 M |
| Dec 2018 | $532.67 M | - |
FAQ
- What is Relay Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Relay Therapeutics?
- What is Relay Therapeutics annual total long term liabilities year-on-year change?
- What is Relay Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Relay Therapeutics?
- What is Relay Therapeutics quarterly long term liabilities year-on-year change?
What is Relay Therapeutics annual total long term liabilities?
The current annual total long term liabilities of RLAY is $61.71 M
What is the all time high annual total long term liabilities for Relay Therapeutics?
Relay Therapeutics all-time high annual total long term liabilities is $561.52 M
What is Relay Therapeutics annual total long term liabilities year-on-year change?
Over the past year, RLAY annual total long term liabilities has changed by -$24.14 M (-28.12%)
What is Relay Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of RLAY is $44.29 M
What is the all time high quarterly long term liabilities for Relay Therapeutics?
Relay Therapeutics all-time high quarterly total long term liabilities is $561.52 M
What is Relay Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, RLAY quarterly total long term liabilities has changed by -$33.55 M (-43.10%)